Cholesterol Drug Could Lower Cancer Risk: New Study Findings
A widely available and cost-effective cholesterol-lowering drug, commonly known as statins, may offer significant benefits beyond heart health by potentially reducing cancer risk reducing cancer risk . According to recent research led by the Mass General Cancer Center and published in Nature Communications , statins might block pathways associated with cancer development due to chronic inflammation in the body. Dr. Shawn Demehri, a principal investigator at the Center for Cancer Immunology and Cutaneous Biology Research Center at Massachusetts General Hospital, and an associate professor of dermatology at Harvard Medical School, emphasized the role of chronic inflammation as a major global cause of cancer. “We investigated the mechanism by which environmental toxins drive the initiation of cancer-prone chronic inflammation in the skin and pancreas. Furthermore, we examined safe and effective therapies to block this pathway to suppress chronic inflammation and its cancer aftermath,...